Making weight loss drugs more accessible
A new report from Reuters confirms that Microsoft founder Bill Gates and PAHO are in discussions about expanding access to weight loss drugs in lower-income countries.
GLP-1 drugs like Mounjaro (tirzepatide) and Wegovy (semaglutide) are now being recognised as tools to tackle long-term health issues like:
- High blood pressure
- Type 2 diabetes
- Heart disease
- Even cancer and dementia risk
Why this matters
Until now, these drugs have mostly been available in wealthier countries, and mainly through private prescriptions. But this new global focus, involving one of the world’s most influential health philanthropists, shows that the health benefits are too big to ignore.
At SlimrChat, we’ve talked a lot about how weight loss drugs don’t just change your size. They can change your life.
Learn how weight loss drugs really work
SlimrChat’s view
The fact that the World Health Organization, Bill Gates, and major regional health bodies are now exploring wider access proves what we’ve always said: this is about health, not vanity.
When the world starts treating these drugs as essential tools, not luxury add-ons, more people everywhere can start the journey to better health.
